121 related articles for article (PubMed ID: 25802144)
1. Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
Vaillant O; El Cheikh K; Warther D; Brevet D; Maynadier M; Bouffard E; Salgues F; Jeanjean A; Puche P; Mazerolles C; Maillard P; Mongin O; Blanchard-Desce M; Raehm L; Rébillard X; Durand JO; Gary-Bobo M; Morère A; Garcia M
Angew Chem Int Ed Engl; 2015 May; 54(20):5952-6. PubMed ID: 25802144
[TBL] [Abstract][Full Text] [Related]
2. Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.
Bouffard E; Mauriello Jimenez C; El Cheikh K; Maynadier M; Basile I; Raehm L; Nguyen C; Gary-Bobo M; Garcia M; Durand JO; Morère A
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181759
[TBL] [Abstract][Full Text] [Related]
3. The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics.
Daurat M; Nguyen C; Dominguez Gil S; Sol V; Chaleix V; Charnay C; Raehm L; El Cheikh K; Morère A; Bernasconi M; Timpanaro A; Garcia M; Cunin F; Roessler J; Durand JO; Gary-Bobo M
Biomater Sci; 2020 Jul; 8(13):3678-3684. PubMed ID: 32469353
[TBL] [Abstract][Full Text] [Related]
4. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Brevet D; Gary-Bobo M; Raehm L; Richeter S; Hocine O; Amro K; Loock B; Couleaud P; Frochot C; Morère A; Maillard P; Garcia M; Durand JO
Chem Commun (Camb); 2009 Mar; (12):1475-7. PubMed ID: 19277361
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
6. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
7. Stable mesoporous silica nanoparticles incorporated with MoS2 and AIE for targeted fluorescence imaging and photothermal therapy of cancer cells.
Wang J; Xu M; Wang K; Chen Z
Colloids Surf B Biointerfaces; 2019 Feb; 174():324-332. PubMed ID: 30472618
[TBL] [Abstract][Full Text] [Related]
8. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of mesoporous silica nanoparticles.
Wu SH; Mou CY; Lin HP
Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
11. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
13. Improved fluorescence imaging and synergistic anticancer phototherapy of hydrosoluble gold nanoclusters assisted by a novel two-level mesoporous canal structured silica nanocarrier.
Yang Y; Wang S; Xu C; Xie A; Shen Y; Zhu M
Chem Commun (Camb); 2018 Mar; 54(22):2731-2734. PubMed ID: 29479592
[TBL] [Abstract][Full Text] [Related]
14. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Basile I; Maynadier M; Vaillant O; Mongin O; Blanchard-Desce M; Morère A; Garcia M; Durand JO; Raehm L
Angew Chem Int Ed Engl; 2011 Nov; 50(48):11425-9. PubMed ID: 21976357
[No Abstract] [Full Text] [Related]
15. Facile incorporation of aggregation-induced emission materials into mesoporous silica nanoparticles for intracellular imaging and cancer therapy.
Zhang X; Zhang X; Wang S; Liu M; Zhang Y; Tao L; Wei Y
ACS Appl Mater Interfaces; 2013 Mar; 5(6):1943-7. PubMed ID: 23363527
[TBL] [Abstract][Full Text] [Related]
16. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new sulfonate and phosphonate derivatives for cation-independent mannose 6-phosphate receptor targeting.
Jeanjean A; Gary-Bobo M; Nirdé P; Leiris S; Garcia M; Morère A
Bioorg Med Chem Lett; 2008 Dec; 18(23):6240-3. PubMed ID: 18929485
[TBL] [Abstract][Full Text] [Related]
18. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
[TBL] [Abstract][Full Text] [Related]
19. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
20. Hybrid smart mesoporous silica nanoparticles for theranostics.
Baleizão C; Farinha JP
Nanomedicine (Lond); 2015; 10(15):2311-4. PubMed ID: 26227810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
